Your browser doesn't support javascript.
loading
Mother and Daughter Perspectives on Genetic Counseling and Testing of Adolescents for Hereditary Breast Cancer Risk.
Jennings, Catherine; Wynn, Julia; Miguel, Cecilia; Levinson, Elana; Florido, Michelle E; White, Melissa; Sands, Colleen Burke; Schwartz, Lisa A; Daly, Mary; O'Toole, Karen; Buys, Saundra S; Glendon, Gordon; Hanna, Danielle; Andrulis, Irene L; Terry, Mary Beth; Chung, Wendy K; Bradbury, Angela.
  • Jennings C; Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York, NY.
  • Wynn J; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Genetic Counseling Graduate Program, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York, NY.
  • Miguel C; Genetic Counseling Graduate Program, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York, NY.
  • Levinson E; Genetic Counseling Graduate Program, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York, NY; Department of Medicine, Columbia University Irving Medical Center, New York, NY.
  • Florido ME; Genetic Counseling Graduate Program, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York, NY; Department of Genetics and Development, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY.
  • White M; Department of Epidemiology, Columbia University Irving Medical Center, New York, NY.
  • Sands CB; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Schwartz LA; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
  • Daly M; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA.
  • O'Toole K; Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT.
  • Buys SS; Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT.
  • Glendon G; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Hanna D; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Andrulis IL; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Terry MB; Department of Epidemiology, Columbia University Irving Medical Center, New York, NY.
  • Chung WK; Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York, NY; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY; Department of Medicine, Columbia University Irving Medical Center, New York, NY. Electronic address: wkc15@columbi
  • Bradbury A; Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
J Pediatr ; 251: 113-119.e7, 2022 12.
Article en En | MEDLINE | ID: mdl-35777474
ABSTRACT

OBJECTIVE:

To evaluate the risks, benefits, and utility of testing for adult-onset hereditary breast and ovarian cancer (HBOC) in adolescents and young adults. STUDY

DESIGN:

We evaluated interest in genetic testing of adolescents for adult-onset HBOC genes through semistructured interviews with mothers and adolescents who had previously participated in breast cancer research or had pursued (mothers) clinical testing for HBOC.

RESULTS:

The majority of mothers (73%) and daughters (75%) were interested in the daughter having genetic testing and were motivated by the future medical utility and current social utility of relieving anxiety and allowing them to prepare. Mothers and daughters both reported that approximately 3 years in the future was the best time to test the daughter regardless of the current age of the daughter. Overall, both mothers and daughters expressed the importance of the involvement of the mother to provide educational and emotional support but ultimately it was the daughter's decision to test. Balancing the independence and maturity of the daughter while reinforcing communication and support within the dyad was a prominent theme throughout the interviews.

CONCLUSIONS:

There is interest among some high-risk adolescents and young adults to engage in genetic counseling and undergo testing. Providing pretest and posttest genetic counseling, assessing preferences for parent involvement, and offering psychosocial support may be important if genetic testing for HBOC is offered to adolescents and young adults before age 25 years.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Madres Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Madres Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article